ProMIS Neurosciences Inc. (PMN) - Dilution Analysis

S-3 filing: PROMIS NEUROSCIENCES INC. is offering common shares, preferred shares, subscription receipts, and debt securities for a total proposed amount of $200,000,000.

10-K filing | 9.0M shares outstanding

S-3 filing: This is an S-3 filing for the resale of up to 13,830,592 common shares by selling securityholders, including shares, common shares issuable upon exercise of Common Share purchase warrants, and common shares issuable upon exercise of Pre-Funded Warrants.

8-K filing: ProMIS Neurosciences Inc. entered into a Securities Purchase Agreement to sell 6,815,296 common shares, Common Share purchase warrants to purchase 6,915,296 Common Shares and Pre-Funded Warrants to purchase 100,000 Common Shares to PIPE Investors.

8-K filing: Stock split one-for-twenty-five | Outstanding: 48,833,799 → 1,953,351

10-Q filing | 48.8M shares outstanding

S-3 filing: This prospectus relates to the resale of common shares by selling securityholders upon exercise of warrants.

S-3 filing: Promis Neurosciences Inc. files an S-3 form to offer common shares, preferred shares, subscription receipts, and debt securities for a total amount of $50,000,000.

10-Q filing | 34.9M shares outstanding

8-K filing: ProMIS Neurosciences Inc. entered into a securities purchase agreement for a registered direct offering of a pre-funded warrant to purchase 984,736 common shares at $0.8124 per share, and a PIPE offering for a warrant to purchase 12,616,821 common shares at $0.1875 per share. ($3.2M proceeds)

10-Q filing | 34.9M shares outstanding

10-K filing | 32.7M shares outstanding

10-Q filing | 30.1M shares outstanding

S-3 filing: Resale of up to 56,514,784 common shares by selling securityholders.

10-Q filing | 19.8M shares outstanding

8-K filing: ProMIS Neurosciences Inc. entered into a Unit Purchase Agreement to sell Common Share Units and Pre-Funded Units to PIPE Investors, expecting to raise $30.3 million in gross proceeds, and will convert Series 2 Preferred Shares into 1,166,667 common shares upon closing. ($60.6M proceeds)

10-Q filing | 19.5M shares outstanding

10-K filing | 18.9M shares outstanding

10-Q filing | 18.5M shares outstanding

S-3/A filing: This is an S-3/A filing for the resale of common shares, pre-funded warrant shares, warrant shares and placement agent shares by selling shareholders and the placement agent.

S-3/A filing: ProMIS Neurosciences Inc. is filing a registration statement on Form S-3 for the proposed public offering of up to US$100,000,000 of any combination of common shares, preferred shares, debt securities, warrants, subscription receipts, and units.

S-3 filing: Promis Neurosciences Inc. files an S-3 form to register an offering of common shares, preferred shares, subscription receipts, and debt securities, with a total proposed amount of $100,000,000.

S-3 filing: This S-3 filing from Promis Neurosciences Inc. relates to the resale of up to 22,128,408 common shares by selling securityholders, including shares, shares underlying pre-funded warrants, common warrants and placement agent warrants.

POS AM filing: This prospectus relates to the issuance by us and the resale by the selling security holders named in this prospectus of up to an aggregate of 1,729,694 of our common shares.

8-K filing: ProMIS Neurosciences Inc. entered into a Unit Purchase Agreement to sell common share units and pre-funded units to PIPE Investors for approximately $20.4 million in gross proceeds, with the final closing expected on August 23, 2023. ($22.19M proceeds)

10-Q filing | 8.6M shares outstanding

10-Q filing | 8.6M shares outstanding

POS AM filing: This is a prospectus for the issuance and resale of up to 1,729,694 common shares of ProMIS Neurosciences Inc.

10-K filing | 8.6M shares outstanding

10-Q filing | 7.2M shares outstanding

S-1/A filing: This S-1/A filing relates to the issuance and resale of up to 1,729,694 common shares by selling shareholders, including shares issuable under a Unit Purchase Agreement and upon exercise of warrants.

S-1/A filing: This is an extraction of standardized offering data from an S-1/A filing, including private placements of units, common shares issued upon warrant exercises, and stock options granted.

S-1 filing: This S-1 filing relates to the offering of 1,729,694 common shares by selling shareholders of ProMIS Neurosciences Inc.

8-K filing: ProMIS Neurosciences Inc. closed an offering of Units, each consisting of one common share and one-quarter of one warrant, with gross proceeds of approximately $7.47 million. ($7.47M proceeds)

10-Q filing | 7.2M shares outstanding